With a sturdy scientific-stage pipeline, Agenus harnesses a combination of proprietary antibody platforms, such as Retrocyte Screen™ and SECANT®, and innovative cell therapy ways, positioning by itself to be a important contributor while in the biotechnology and immunotherapy arena. The